Panelists Question Efficacy, Immunogenicity Studies for Biosimilars
November 3rd 2020Certain biosimilar studies are performed out of an abundance of caution and good marketing sense, although science has leapfrogged the need for these trials, panelists said at the Terrapinn Festival of Biologics Basel 2020.